Insider Trading
| EXAS Stock | USD 45.00 1.96 4.55% |
Slightly above 54% of EXACT Sciences' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that some traders are interested. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.
EXACT |
Filed transaction by EXACT Sciences Executive. Insider Public Trading
Read at gurufocus.com
 |
EXACT Sciences Fundamental Analysis
We analyze EXACT Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
EXACT Sciences is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
EXACT Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EXACT Sciences stock to make a market-neutral strategy. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with similar companies.
Peers
EXACT Sciences Related Equities
| CDNA | Caredx | 7.14 | ||||
| GH | Guardant Health | 5.54 | ||||
| NTRA | Natera | 4.01 | ||||
| MYGN | Myriad Genetics | 3.81 | ||||
| A | Agilent Technologies | 3.28 | ||||
| DHR | Danaher | 3.26 | ||||
| CSTL | Castle Biosciences | 2.83 | ||||
| TMO | Thermo Fisher | 2.67 | ||||
| CRL | Charles River | 2.46 | ||||
| TWST | Twist Bioscience | 2.15 | ||||
| ILMN | Illumina | 1.84 |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.